These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1185 related articles for article (PubMed ID: 25600769)
1. A novel ent-kaurane diterpenoid executes antitumor function in colorectal cancer cells by inhibiting Wnt/β-catenin signaling. Ye Q; Yao G; Zhang M; Guo G; Hu Y; Jiang J; Cheng L; Shi J; Li H; Zhang Y; Liu H Carcinogenesis; 2015 Mar; 36(3):318-26. PubMed ID: 25600769 [TBL] [Abstract][Full Text] [Related]
2. Henryin, an ent-kaurane diterpenoid, inhibits Wnt signaling through interference with β-catenin/TCF4 interaction in colorectal cancer cells. Li X; Pu J; Jiang S; Su J; Kong L; Mao B; Sun H; Li Y PLoS One; 2013; 8(7):e68525. PubMed ID: 23844215 [TBL] [Abstract][Full Text] [Related]
3. Preclinical evaluation of destruxin B as a novel Wnt signaling target suppressing proliferation and metastasis of colorectal cancer using non-invasive bioluminescence imaging. Yeh CT; Rao YK; Ye M; Wu WS; Chang TC; Wang LS; Wu CH; Wu AT; Tzeng YM Toxicol Appl Pharmacol; 2012 May; 261(1):31-41. PubMed ID: 22465936 [TBL] [Abstract][Full Text] [Related]
4. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors. Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963 [TBL] [Abstract][Full Text] [Related]
5. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression. Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398 [TBL] [Abstract][Full Text] [Related]
6. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis. Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932 [TBL] [Abstract][Full Text] [Related]
7. Attenuation of the beta-catenin/TCF4 complex in colorectal cancer cells induces several growth-suppressive microRNAs that target cancer promoting genes. Schepeler T; Holm A; Halvey P; Nordentoft I; Lamy P; Riising EM; Christensen LL; Thorsen K; Liebler DC; Helin K; Ørntoft TF; Andersen CL Oncogene; 2012 May; 31(22):2750-60. PubMed ID: 21963845 [TBL] [Abstract][Full Text] [Related]
8. Oncogenic KRAS signalling promotes the Wnt/β-catenin pathway through LRP6 in colorectal cancer. Lemieux E; Cagnol S; Beaudry K; Carrier J; Rivard N Oncogene; 2015 Sep; 34(38):4914-27. PubMed ID: 25500543 [TBL] [Abstract][Full Text] [Related]
9. Wnt/β-catenin signaling mediates the antitumor activity of magnolol in colorectal cancer cells. Kang YJ; Park HJ; Chung HJ; Min HY; Park EJ; Lee MA; Shin Y; Lee SK Mol Pharmacol; 2012 Aug; 82(2):168-77. PubMed ID: 22550094 [TBL] [Abstract][Full Text] [Related]
10. Pimozide suppresses colorectal cancer via inhibition of Wnt/β-catenin signaling pathway. Ren Y; Tao J; Jiang Z; Guo D; Tang J Life Sci; 2018 Sep; 209():267-273. PubMed ID: 30107167 [TBL] [Abstract][Full Text] [Related]
11. Structure-based discovery of a novel inhibitor targeting the β-catenin/Tcf4 interaction. Tian W; Han X; Yan M; Xu Y; Duggineni S; Lin N; Luo G; Li YM; Han X; Huang Z; An J Biochemistry; 2012 Jan; 51(2):724-31. PubMed ID: 22224445 [TBL] [Abstract][Full Text] [Related]
12. ZEB1 and TCF4 reciprocally modulate their transcriptional activities to regulate Wnt target gene expression. Sánchez-Tilló E; de Barrios O; Valls E; Darling DS; Castells A; Postigo A Oncogene; 2015 Nov; 34(46):5760-70. PubMed ID: 26387539 [TBL] [Abstract][Full Text] [Related]
13. The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/β-catenin signaling. Han P; Li JW; Zhang BM; Lv JC; Li YM; Gu XY; Yu ZW; Jia YH; Bai XF; Li L; Liu YL; Cui BB Mol Cancer; 2017 Jan; 16(1):9. PubMed ID: 28086904 [TBL] [Abstract][Full Text] [Related]
14. IWR-1 inhibits epithelial-mesenchymal transition of colorectal cancer cells through suppressing Wnt/β-catenin signaling as well as survivin expression. Lee SC; Kim OH; Lee SK; Kim SJ Oncotarget; 2015 Sep; 6(29):27146-59. PubMed ID: 26450645 [TBL] [Abstract][Full Text] [Related]
15. microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis. Zhang N; Li X; Wu CW; Dong Y; Cai M; Mok MT; Wang H; Chen J; Ng SS; Chen M; Sung JJ; Yu J Oncogene; 2013 Oct; 32(42):5078-88. PubMed ID: 23208495 [TBL] [Abstract][Full Text] [Related]
16. Scutellaria barbata D. Don inhibits colorectal cancer growth via suppression of Wnt/β-catenin signaling pathway. Wei LH; Lin JM; Chu JF; Chen HW; Li QY; Peng J Chin J Integr Med; 2017 Nov; 23(11):858-863. PubMed ID: 29080197 [TBL] [Abstract][Full Text] [Related]
17. Toosendanin-induced apoptosis in colorectal cancer cells is associated with the κ-opioid receptor/β-catenin signaling axis. Wang H; Wen C; Chen S; Wang F; He L; Li W; Zhou Q; Yu WK; Huang L; Chen J; Liu R; Li W; Yang X; Liu H Biochem Pharmacol; 2020 Jul; 177():114014. PubMed ID: 32387457 [TBL] [Abstract][Full Text] [Related]
18. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway. Shan BE; Wang MX; Li RQ Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933 [TBL] [Abstract][Full Text] [Related]
19. Small molecule antagonists of Tcf4/beta-catenin complex inhibit the growth of HCC cells in vitro and in vivo. Wei W; Chua MS; Grepper S; So S Int J Cancer; 2010 May; 126(10):2426-36. PubMed ID: 19662654 [TBL] [Abstract][Full Text] [Related]
20. Salinomycin inhibits metastatic colorectal cancer growth and interferes with Wnt/β-catenin signaling in CD133 Klose J; Eissele J; Volz C; Schmitt S; Ritter A; Ying S; Schmidt T; Heger U; Schneider M; Ulrich A BMC Cancer; 2016 Nov; 16(1):896. PubMed ID: 27855654 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]